Search ARM

Other Industry Events



Cell & Gene Connect

Boston

September 4, 2018

Featuring Morrie Ruffin, Co-Founder of Alliance for Regenerative Medicine as well as industry leaders such as:

  • Gabriela Apiou – Director of Strategic Alliances, Director of Translational Research Training & Development, Mass General Hospital Research Institute
  • Boro Dropulic – Chief Scientific Officer and General Manager, Lentigen Technology, Inc A Miltenyi Company
  • Mike Druckman – Partner, Hogan Lovells,  Head, Cell, Tissue, and Gene Therapies Working Group
  • Dan Gincel – Executive Director of Maryland Stem Cell Research Fund
  • Timothy Herpin – Chief Business Officer, Caribou Biosciences
  • Lawrence Klein – VP, Strategy and Corporate Development, CRISPR Therapeutics
  • Walter Kowtoniuk – Third Rock Ventures, Principal, and Global Genes Advisor
  • Janet Lambert – CEO, Alliance for Regenerative Medicine
  • Amanda Micklus – Principal Analyst, Datamonitor Healthcare
  • Timothy J. Miller – President and CSO, Abeona Therapeutics, Inc.
  • Sarah Haecker Meeks – VP Business Development, Synpromics, Ltd
  • Patricia Reilly – Head of Intelligence, Pharma Intelligence
  • Issi Rozen – Chief Business Officer, Broad Institute

Register for the 1-day program for a special rate of $499